收费全文 | 19330篇 |
免费 | 1170篇 |
国内免费 | 641篇 |
耳鼻咽喉 | 560篇 |
儿科学 | 376篇 |
妇产科学 | 244篇 |
基础医学 | 2837篇 |
口腔科学 | 766篇 |
临床医学 | 1397篇 |
内科学 | 2512篇 |
皮肤病学 | 313篇 |
神经病学 | 1070篇 |
特种医学 | 358篇 |
外国民族医学 | 2篇 |
外科学 | 2128篇 |
综合类 | 2601篇 |
现状与发展 | 1篇 |
预防医学 | 785篇 |
眼科学 | 1811篇 |
药学 | 2189篇 |
7篇 | |
中国医学 | 650篇 |
肿瘤学 | 534篇 |
2024年 | 40篇 |
2023年 | 243篇 |
2022年 | 500篇 |
2021年 | 719篇 |
2020年 | 531篇 |
2019年 | 488篇 |
2018年 | 522篇 |
2017年 | 474篇 |
2016年 | 462篇 |
2015年 | 552篇 |
2014年 | 867篇 |
2013年 | 1117篇 |
2012年 | 885篇 |
2011年 | 945篇 |
2010年 | 908篇 |
2009年 | 889篇 |
2008年 | 916篇 |
2007年 | 881篇 |
2006年 | 805篇 |
2005年 | 818篇 |
2004年 | 682篇 |
2003年 | 628篇 |
2002年 | 534篇 |
2001年 | 496篇 |
2000年 | 382篇 |
1999年 | 417篇 |
1998年 | 394篇 |
1997年 | 375篇 |
1996年 | 307篇 |
1995年 | 281篇 |
1994年 | 273篇 |
1993年 | 219篇 |
1992年 | 242篇 |
1991年 | 209篇 |
1990年 | 198篇 |
1989年 | 192篇 |
1988年 | 171篇 |
1987年 | 157篇 |
1986年 | 145篇 |
1985年 | 218篇 |
1984年 | 180篇 |
1983年 | 128篇 |
1982年 | 176篇 |
1981年 | 136篇 |
1980年 | 122篇 |
1979年 | 80篇 |
1978年 | 71篇 |
1977年 | 58篇 |
1976年 | 40篇 |
1975年 | 19篇 |
Background
Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.Objectives
To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.Methods
Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.Results
Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.Conclusions
These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study. 相似文献Methods: Case report and the literature search of all English articles on delivery while on ECMO in patients with ARDS caused by influenza.
Results: A 25-year-old pregnant woman was initiated with ECMO due to severe ARDS caused by influenza A (H1N1) virus. When the patient had symptoms of colporrhagia and uterine contractions, the medical team decided to start labour induction while on ECMO. There were in total five case reports identified. Maternal oxygenation was improved after delivery and ECMO was successfully discontinued.
Conclusions: Maternal oxygenation was improved after delivery, which may be beneficial to reduce the duration of ECMO. Caesarean section (CS) may be the most used mode and labour induction could be another option. The procedure should be performed by an experienced ECMO team, cooperating with the obstetrician, anaesthesiologist, and ICU doctors. 相似文献